About: prostate cancer screening

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: prostate cancer screening Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

medical examination

Attributes	Values
rdf:type	Item
owl:sameAs	prostate cancer screening
description	medizinische Untersuchung (de) medical examination (en)
rdfs:label	cribratge del càncer prostàtic (ca) dépistage du cancer de la prostate (fr) presejanje za raka prostate (sl) prevención del cáncer de próstata (es) prostate cancer screening (en) скрининг рака простаты (ru) 前列腺癌篩查 (zh) فحوص الكشف المبكر عن سرطان البروستات (ar)
skos:prefLabel	cribratge del càncer prostàtic (ca) dépistage du cancer de la prostate (fr) presejanje za raka prostate (sl) prevención del cáncer de próstata (es) prostate cancer screening (en) скрининг рака простаты (ru) 前列腺癌篩查 (zh) فحوص الكشف المبكر عن سرطان البروستات (ar)
name	cribratge del càncer prostàtic (ca) dépistage du cancer de la prostate (fr) presejanje za raka prostate (sl) prevención del cáncer de próstata (es) prostate cancer screening (en) скрининг рака простаты (ru) 前列腺癌篩查 (zh) فحوص الكشف المبكر عن سرطان البروستات (ar)
Freebase ID	wds:Q7250979-0FEDE375-EA3A-4C4F-A910-FE54C8CA2EB2
Freebase ID	/m/096zkl
instance of	wds:Q7250979-b6dd23b7-462c-fa79-41c6-3c16ba10ed00
instance of	medical test
facet of	wds:Q7250979-a0166e16-4f75-61a0-04b3-f4d34c11f1e8
facet of	men's health
subclass of	wds:Q7250979-1832b34a-410b-9c78-4a72-0f68b9cf6f14 wds:Q7250979-48ec3efe-4303-3567-93c2-d640e7cb144e
subclass of	cancer screening intimate examination
skos:altLabel	Prevencion del cancer de prostata (es) Prevencion del cancer de próstata (es) Prevencion del cáncer de prostata (es) Prevencion del cáncer de próstata (es) Prevención del cancer de próstata (es) cribratge del càncer de pròstata (ca)
OpenAlex ID	wds:Q7250979-E4B2288E-3114-4FDF-8D1C-4A856F999524
Microsoft Academic ID	wds:Q7250979-8444E3C1-57D8-43F6-92F5-E575ED246284
Microsoft Academic ID	https://makg.org/entity/2775941076
OpenAlex ID	C2775941076
Microsoft Academic ID	2775941076
is about of	prostate cancer screening https://www.wikidata.org/wiki/Special:EntityData/Q7250979 Prostate cancer screening https://fr.wikipedia.org/wiki/D%C3%A9pistage_du_cancer_de_la_prostate https://ar.wikipedia.org/wiki/%D9%81%D8%AD%D9%88%D8%B5_%D8%A7%D9%84%D9%83%D8%B4%D9%81_%D8%A7%D9%84%D9%85%D8%A8%D9%83%D8%B1_%D8%B9%D9%86_%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A7%D9%84%D8%A8%D8%B1%D9%88%D8%B3%D8%AA%D8%A7%D8%AA https://es.wikipedia.org/wiki/Prevenci%C3%B3n_del_c%C3%A1ncer_de_pr%C3%B3stata
is main subject of	Incorporating genomics into breast and prostate cancer screening: assessing the implications Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial Randomised prostate cancer screening trial: 20 year follow-up 15-year followup of a population based prostate cancer screening study Prostate cancer screening: what we know, don't know, and believe Increasing prostate cancer screening in African American men with peer-educator and client-navigator interventions More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Prostate cancer screening: knowledge, experiences and attitudes of men aged 40-79 years Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling Prostate Cancer Screening and the Associated Controversy Prostate cancer: screening, diagnosis, and management Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies. Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program Prostate cancer screening: Canadian guidelines 2011 Family history and prostate cancer screening with prostate-specific antigen Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study Primary care physicians' use of an informed decision-making process for prostate cancer screening The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening Prostate cancer screening practices and beliefs Use of prostate-specific antigen for prostate cancer screening in primary care practice. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening Prostate cancer screening (United States). Disease-specific survival following routine prostate cancer screening by digital rectal examination. Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica. Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up Historical prostate cancer screening and treatment outcomes from a single institution Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial Prostate Cancer Screening Decisions Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices. Perceived benefits: a predictor of participation in prostate cancer screening Urinary symptoms as a predictor for participation in prostate cancer screening among African American men. The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later. Relationship between body mass index and prostate cancer screening in the United States Prostate cancer screening between low-income African-American and Caucasian men.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software